Jong‐Lyul Ghim

894 total citations
58 papers, 666 citations indexed

About

Jong‐Lyul Ghim is a scholar working on Pharmacology, Pharmacology and Surgery. According to data from OpenAlex, Jong‐Lyul Ghim has authored 58 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 15 papers in Pharmacology and 12 papers in Surgery. Recurrent topics in Jong‐Lyul Ghim's work include Pharmacogenetics and Drug Metabolism (15 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Jong‐Lyul Ghim is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Jong‐Lyul Ghim collaborates with scholars based in South Korea, United States and Vietnam. Jong‐Lyul Ghim's co-authors include Jae‐Gook Shin, Dong‐Hyun Kim, Sangzin Ahn, Kyun‐Seop Bae, Sang‐Heon Cho, Jin Ah Jung, Eun‐Young Kim, Hyeong-Seok Lim, Minkyung Oh and Seung Heon Lee and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Lipid Research and British Journal of Pharmacology.

In The Last Decade

Jong‐Lyul Ghim

57 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jong‐Lyul Ghim South Korea 15 143 128 117 88 87 58 666
Xiao‐cong Zuo China 16 87 0.6× 99 0.8× 82 0.7× 64 0.7× 130 1.5× 59 929
Kevin Sneed United States 15 94 0.7× 214 1.7× 158 1.4× 132 1.5× 191 2.2× 39 1.0k
Huaijun Zhu China 16 74 0.5× 113 0.9× 100 0.9× 85 1.0× 197 2.3× 60 772
Christian Laveille France 14 202 1.4× 102 0.8× 117 1.0× 152 1.7× 120 1.4× 33 1.0k
Akiko Tamon Japan 8 189 1.3× 72 0.6× 87 0.7× 67 0.8× 231 2.7× 12 969
Barbara Schug Germany 16 99 0.7× 112 0.9× 110 0.9× 72 0.8× 151 1.7× 47 991
In‐Jin Jang South Korea 14 146 1.0× 222 1.7× 70 0.6× 38 0.4× 105 1.2× 27 660
Kaori Kadoyama Japan 14 264 1.8× 99 0.8× 150 1.3× 90 1.0× 126 1.4× 25 1.3k
Masayuki Hashiguchi Japan 16 71 0.5× 100 0.8× 110 0.9× 163 1.9× 151 1.7× 64 936
Kristin D. Marciante United States 15 62 0.4× 194 1.5× 101 0.9× 114 1.3× 145 1.7× 17 766

Countries citing papers authored by Jong‐Lyul Ghim

Since Specialization
Citations

This map shows the geographic impact of Jong‐Lyul Ghim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong‐Lyul Ghim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong‐Lyul Ghim more than expected).

Fields of papers citing papers by Jong‐Lyul Ghim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong‐Lyul Ghim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong‐Lyul Ghim. The network helps show where Jong‐Lyul Ghim may publish in the future.

Co-authorship network of co-authors of Jong‐Lyul Ghim

This figure shows the co-authorship network connecting the top 25 collaborators of Jong‐Lyul Ghim. A scholar is included among the top collaborators of Jong‐Lyul Ghim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jong‐Lyul Ghim. Jong‐Lyul Ghim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Oh, Minkyung, et al.. (2023). Evaluation of pharmacokinetic drug-drug interaction between tegoprazan and clarithromycin in healthy subjects. Translational and Clinical Pharmacology. 31(2). 114–114. 4 indexed citations
3.
Ghim, Jong‐Lyul & Sangzin Ahn. (2023). Transforming clinical trials: the emerging roles of large language models. Translational and Clinical Pharmacology. 31(3). 131–131. 30 indexed citations
4.
Kim, Eun‐Young, Seok Jin Choi, Jong‐Lyul Ghim, et al.. (2021). Associations between HLA-A, -B, and -C alleles and iodinated contrast media–induced hypersensitivity in Koreans. Translational and Clinical Pharmacology. 29(2). 107–107. 3 indexed citations
5.
Phương, Nguyễn Thị Thu, Jin Ah Jung, Jong‐Lyul Ghim, et al.. (2021). Para‐aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research. British Journal of Clinical Pharmacology. 88(3). 1159–1169. 4 indexed citations
6.
Kim, Eun‐Young, Mi‐Yeong Kim, Chan Sun Park, et al.. (2019). Antiepileptic drug-induced severe cutaneous adverse reactions and HLA alleles: A report of five cases with lymphocyte activation test. Translational and Clinical Pharmacology. 27(2). 64–64. 6 indexed citations
7.
Cho, Sang‐Heon, Seunghoon Han, Jong‐Lyul Ghim, et al.. (2019). A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males. BioDrugs. 33(2). 173–181. 13 indexed citations
8.
Kim, Jung‐Ryul, Jin Ah Jung, Wooseong Huh, et al.. (2019). Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects. BioMed Research International. 2019. 1–6. 6 indexed citations
9.
Ghim, Jong‐Lyul, Nguyễn Thị Thu Phương, Min Jung Kim, et al.. (2019). <p>Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets</p>. Drug Design Development and Therapy. Volume 13. 1623–1632. 10 indexed citations
11.
Ghim, Jong‐Lyul, et al.. (2017). Role of the ABCB1 Drug Transporter Polymorphisms in the Pharmacokinetics of Oseltamivir in Humans: a Preliminary Report. Journal of Korean Medical Science. 32(9). 1542–1542. 1 indexed citations
12.
Kim, Yo Han, Sang‐Heon Cho, Jong‐Lyul Ghim, et al.. (2015). Pharmacokinetic comparison of sustained- and&nbsp;immediate-release formulations of cilostazol after multiple oral doses in fed healthy male Korean volunteers. Drug Design Development and Therapy. 9. 3571–3571. 8 indexed citations
13.
Kim, Hyun-Mi, Jong‐Lyul Ghim, Seung Heon Lee, et al.. (2014). Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography–electrospray ionization–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 102. 9–16. 85 indexed citations
14.
Jarrar, Yazun, Kyung‐Ah Seo, Jong‐Lyul Ghim, et al.. (2014). Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation. Journal of Lipid Research. 55(11). 2334–2342. 17 indexed citations
15.
Seo, Kyung‐Ah, Kye Jung Shin, Su‐Jun Lee, et al.. (2013). Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4. Drug Metabolism and Disposition. 41(8). 1529–1537. 14 indexed citations
16.
Yeo, Chang‐Woo, Minkyung Oh, Jong‐Lyul Ghim, et al.. (2013). The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects. British Journal of Clinical Pharmacology. 77(5). 821–830. 16 indexed citations
17.
Cho, Sang‐Heon, Jong‐Lyul Ghim, Jin Ah Jung, et al.. (2012). Pharmacokinetic Comparison of 2 Formulations of Anastrozole (1 mg) in Healthy Korean Male Volunteers: A Randomized, Single-Dose, 2-Period, 2-Sequence, Crossover Study. Clinical Therapeutics. 34(2). 305–313. 6 indexed citations
18.
Lim, Hyeong-Seok, Sang‐Heon Cho, Jong‐Lyul Ghim, et al.. (2012). Assessment of the influence of severe renal impairment on the pharmacokinetics of mirodenafil in Korean male volunteers. International Journal of Clinical Pharmacology and Therapeutics. 50(12). 880–888. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026